Eyepoint Historical Financial Ratios
| EYPT Stock | USD 8.25 0.21 2.48% |
Eyepoint Pharmaceuticals is recently reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 3.13 or Days Sales Outstanding of 6.07 will help investors to properly organize and evaluate Eyepoint Pharmaceuticals financial condition quickly.
Eyepoint |
About Eyepoint Financial Ratios Analysis
Eyepoint PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Eyepoint Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Eyepoint financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Eyepoint Pharmaceuticals history.
Eyepoint Pharmaceuticals Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Eyepoint Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Eyepoint Pharmaceuticals sales, a figure that is much harder to manipulate than other Eyepoint Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Eyepoint Pharmaceuticals. There are two different methods for calculating Eyepoint Pharmaceuticals invested capital: operating approach and financing approach. Understanding Eyepoint Pharmaceuticals invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Most ratios from Eyepoint Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Eyepoint Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyepoint Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Eyepoint Stock please use our How to Invest in Eyepoint Pharmaceuticals guide.At this time, Eyepoint Pharmaceuticals' EV To Operating Cash Flow is comparatively stable compared to the past year. Current Ratio is likely to gain to 5.86 in 2024, whereas Days Sales Outstanding is likely to drop 6.07 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 181.36 | 136.67 | 6.39 | 6.07 | PTB Ratio | 1.91 | 1.36 | 3.29 | 3.13 |
Eyepoint Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Eyepoint Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eyepoint Stock Analysis
When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.